SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/28/22 NOV Inc. 10-Q 9/30/22 75:13M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 3.80M 6: EX-95 Mine-Safety Disclosure HTML 138K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 25K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 23K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 23K 12: R1 Document and Entity Information HTML 73K 13: R2 Consolidated Balance Sheets (Unaudited) HTML 150K 14: R3 Consolidated Balance Sheets (Unaudited) HTML 29K (Parenthetical) 15: R4 Consolidated Statements of Income (Loss) HTML 117K (Unaudited) 16: R5 Consolidated Statements of Comprehensive Loss HTML 53K (Unaudited) 17: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 116K 18: R7 Consolidated Statements of Stockholders' Equity HTML 92K (Unaudited) 19: R8 Consolidated Statements of Stockholders' Equity HTML 23K (Unaudited) (Parenthetical) 20: R9 Basis of Presentation HTML 27K 21: R10 Inventories, net HTML 55K 22: R11 Accrued Liabilities HTML 70K 23: R12 Accumulated Other Comprehensive Income (Loss) HTML 261K 24: R13 Segments HTML 136K 25: R14 Impairment and Other Items HTML 41K 26: R15 Revenue HTML 472K 27: R16 Leases HTML 72K 28: R17 Debt HTML 77K 29: R18 Income Taxes HTML 29K 30: R19 Stock-Based Compensation HTML 32K 31: R20 Derivative Financial Instruments HTML 190K 32: R21 Net Income (Loss) Attributable to Company Per HTML 118K Share 33: R22 Cash Dividends HTML 26K 34: R23 Commitments and Contingencies HTML 41K 35: R24 New Accounting Pronouncements HTML 35K 36: R25 Basis of Presentation (Policies) HTML 31K 37: R26 Inventories, net (Tables) HTML 55K 38: R27 Accrued Liabilities (Tables) HTML 68K 39: R28 Accumulated Other Comprehensive Income (Loss) HTML 255K (Tables) 40: R29 Segments (Tables) HTML 131K 41: R30 Revenue (Tables) HTML 461K 42: R31 Leases (Tables) HTML 69K 43: R32 Debt (Tables) HTML 59K 44: R33 Derivative Financial Instruments (Tables) HTML 180K 45: R34 Net Income (Loss) Attributable to Company Per HTML 112K Share (Tables) 46: R35 Inventories, net - Inventories (Detail) HTML 35K 47: R36 Accrued Liabilities - Accrued Liabilities (Detail) HTML 43K 48: R37 Accumulated Other Comprehensive Income (Loss) - HTML 51K Components of Accumulated Other Comprehensive Income (Loss) (Detail) 49: R38 Accumulated Other Comprehensive Income (Loss) - HTML 59K Components of Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) (Detail) 50: R39 Accumulated Other Comprehensive Income (Loss) - HTML 25K Additional Information (Detail) 51: R40 Segments - Operating Segments (Detail) HTML 42K 52: R41 Segments - Additional Information (Detail) HTML 23K 53: R42 Impairment and Other Items - Additional HTML 63K Information (Detail) 54: R43 Revenue - Summary of Disaggregate Revenue by HTML 76K Destinations (Detail) 55: R44 Revenue - Additional Information (Detail) HTML 29K 56: R45 Revenue - Additional Information (Detail 1) HTML 30K 57: R46 Revenue - Summary of Changes in Carrying Amount of HTML 42K Contract Assets and Contract Liabilities (Detail) 58: R47 Leases - Schedule of Components of Leases (Detail) HTML 34K 59: R48 Debt - Debt (Detail) HTML 38K 60: R49 Debt - Debt (Parenthetical) (Detail) HTML 34K 61: R50 Debt - Additional Information (Detail) HTML 72K 62: R51 Income Taxes - Additional Information (Detail) HTML 23K 63: R52 Stock-Based Compensation - Additional Information HTML 35K (Detail) 64: R53 Derivative Financial Instruments - Outstanding HTML 29K Foreign Currency Forward Contracts (Detail) 65: R54 Derivative Financial Instruments - Additional HTML 26K Information (Detail) 66: R55 Derivative Financial Instruments - Derivative HTML 42K Instruments and their Balance Sheet Classifications (Detail) 67: R56 Net Income (Loss) Attributable to Company Per HTML 59K Share - Computation of Weighted Average Basic and Diluted Shares Outstanding (Detail) 68: R57 Net Income (Loss) Attributable to Company Per HTML 24K Share - Additional Information (Detail) 69: R58 Cash Dividends - Additional Information (Detail) HTML 23K 70: R59 Commitments and Contingencies - Additional HTML 28K Information (Detail) 73: XML IDEA XML File -- Filing Summary XML 135K 71: XML XBRL Instance -- nov-20220930_htm XML 3.57M 72: EXCEL IDEA Workbook of Financial Reports XLSX 111K 8: EX-101.CAL XBRL Calculations -- nov-20220930_cal XML 161K 9: EX-101.DEF XBRL Definitions -- nov-20220930_def XML 344K 11: EX-101.LAB XBRL Labels -- nov-20220930_lab XML 973K 10: EX-101.PRE XBRL Presentations -- nov-20220930_pre XML 690K 7: EX-101.SCH XBRL Schema -- nov-20220930 XSD 135K 74: JSON XBRL Instance as JSON Data -- MetaLinks 354± 542K 75: ZIP XBRL Zipped Folder -- 0000950170-22-020421-xbrl Zip 569K
EX-31.1 |
Exhibit 31.1
CERTIFICATION
I, Clay C. Williams, certify that:
1. I have reviewed this quarterly report on Form 10-Q of NOV Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: October 28, 2022
By: |
|
/s/ Clay C. Williams |
Chairman, President and Chief Executive Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 10/28/22 | 8-K | ||
For Period end: | 9/30/22 | 4 | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/12/22 NOV Inc. 8-K:5,9 7/11/22 11:182K Donnelley … Solutions/FA 12/22/20 NOV Inc. 8-K:5,7,9 12/21/20 13:460K Donnelley … Solutions/FA |